Biolog, National Science Foundation, Euroscreen and Cephalon, and Sertanty and Specs | GenomeWeb

Biolog Recently Wins $2M in NIH Grants; Firm to Further Develop Phenotype Microrrary

Biolog has pocked approximately $2 million through four recent grants from the US National Institutes of Health, according to the NIH.

The company is developing living mammalian cell arrays for drug-discovery and -development applications. The four new grants, which the NIH said are effective as of Dec. 26, include:

• $920,940 for the detection of bioterrorism agents with [the company’s phenotype microarray] technology;

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.